Your browser doesn't support javascript.
loading
Prostate cancer and PARP inhibitors: progress and challenges.
Teyssonneau, Diego; Margot, Henri; Cabart, Mathilde; Anonnay, Mylène; Sargos, Paul; Vuong, Nam-Son; Soubeyran, Isabelle; Sevenet, Nicolas; Roubaud, Guilhem.
Afiliação
  • Teyssonneau D; Department of Medical Oncology, Institut Bergonie, Bordeaux, France. d.teyssonneau@bordeaux.unicancer.fr.
  • Margot H; Department of Genetic, Institut Bergonie, Bordeaux, France.
  • Cabart M; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
  • Anonnay M; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
  • Sargos P; Department of Radiotherapy, Institut Bergonie, Bordeaux, France.
  • Vuong NS; Department of Urology, Clinique Saint-Augustin, Bordeaux, France.
  • Soubeyran I; Department of Biopathology, Institut Bergonie, Bordeaux, France.
  • Sevenet N; Department of Genetic, Institut Bergonie, Bordeaux, France.
  • Roubaud G; Department of Medical Oncology, Institut Bergonie, Bordeaux, France.
J Hematol Oncol ; 14(1): 51, 2021 03 29.
Article em En | MEDLINE | ID: mdl-33781305
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reparo do DNA / Neoplasias de Próstata Resistentes à Castração / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Humans / Male Idioma: En Revista: J Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reparo do DNA / Neoplasias de Próstata Resistentes à Castração / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Humans / Male Idioma: En Revista: J Hematol Oncol Ano de publicação: 2021 Tipo de documento: Article